Logo image
Identifying Post-Translational Modifiers of Tau Protein as Clinically Meaningful Markers of Alzheimer's Disease
Thesis   Open access

Identifying Post-Translational Modifiers of Tau Protein as Clinically Meaningful Markers of Alzheimer's Disease

Kelvin James Williamson
University of West Florida Libraries
Master of Science (MS), University of West Florida
2023

Metrics

34 File views/ downloads
53 Record Views

Abstract

Alzheimer’s disease (AD) is a neurodegenerative process that leads to significantcognitive disfunction and memory loss. It is characterized by the presence of neurofibrillary tangles (NFTs) and amyloid-beta plaques (Aβ). These NFT’s are the result of the aggregation of tau proteins in the neurons, leading to the axon shrinkage and neuronal dysfunction. During normal aging or in the presence of disease, the tau protein undergoes various post-translational modifications (PTMs). This study investigated the differences in these PTMs found between AD and cognitively normal individuals, focusing on the ubiquitination of tau (Ub). To do so, a constrained 7-mer (C7C) peptide phage library was panned to determine the presence or absence of ubiquitinated tau for use as a biomarker for AD. After panning of the AD and control CSF, phage was initially isolated selective toward tau isolated from AD subjects. Iterative panning of this phage pool was conducted using a deubiquitinating enzyme (DUB). Panning with the DUB resulted in phage selectively bound to AD tau in a ubiquitin-dependent manner. Overall, phage display using the C7C library offered an easily measurable method of detection of tau proteins, that distinguished AD subjects from controls. These findings are a potential biomarker and detection method that could be used for potential early detection of AD in combination with other AD biomarkers.
pdf
dentifying Post-Translational Modifiers of Tau Protein as Clinically Meaningful Markers of Alzheimer's Disease1.58 MBDownloadView
Preprint Thesis pdf Open Access

Details

Logo image